Indiana University Health

Academic Hematopathologist with the Largest Referral Base in Indiana

Indianapolis, IN

full-time
Non clinical

The Department of Pathology and Laboratory Medicine at the Indiana University School of Medicine (IUSM) in conjunction with IU Health Physicians (IUHP), is seeking an academic hematopathologist to join its expanding faculty.

The individual selected will be part of the Division of Hematopathology that provides expert diagnostic and consultative services to Indiana University Health (IU Health) which includes Methodist Hospital, Indiana University Hospital, Riley Hospital for Children, IU Health West, IU Health North, IU Health Arnett, and a number of smaller hospitals. The division also serves Eskenazi Health and the Richard L. Roudebush VA Medical Center. The successful candidate will join a collaborative group of hematopathologists with sign-out activities based in a central location, the IU Health Pathology Laboratory (IUHPL) in the downtown Indianapolis campus. The academic rank is open and will be determined by qualifications and level of experience.

Responsibilities:

  • Provide diagnostic services including sign-out of tissue hematopathology, flow cytometry, peripheral blood, and fluids, molecular hematopathology and/or coagulation.

  • Pursue clinical and translational research.

  • Actively participate in educational activities including ACGME-accredited and non-accredited trainees

  • Laboratory leadership responsibilities are available for qualified candidates

Our Ideal Candidate:

  • Is academically-oriented.

  • Will take advantage of outstanding opportunities for translational and collaborative research.

  • Interest in lymphoma diagnostics is desirable

Qualifications:

  • Applicants must be certified by the American Board of Pathology in Anatomic and Clinical Pathology

  • Applicants must also be qualified for medical licensure in the state of Indiana

  • Fellowship in Hematopathology

  • Doctorate or Terminal degree is required

Posted September 23, 2024